Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”

• Published in: Journal of obesity Vol. 2019; no. 2019; pp. 1 - 2
• Main Authors: Wszelaki, Natalia, Chong, Pee-Win, Bothe, Gordana, Seibt, Stephanie, Bongartz, Udo, Uebelhack, Ralf, De Costa, Patricia
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 2019; Hindawi; John Wiley & Sons, Inc; Wiley
• Subjects: Body weight; Erratum; Investigations; Logic programming; Obesity
• ISSN: 2090-0708; 2090-0716; 2090-0716
• DOI: 10.1155/2019/6189724

In the article titled “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” [1], there was an error in the legend of Figure 3 that occurred during the production stage, as the color of the placebo results/bars has been replaced by the colors of the high dose results/bars and vice versa.